ISCHEMIA-CKD EXTEND is the long-term follow-up of surviving participants (projected median of 9 years) from the ISCHEMIA-CKD trial, a companion trial that ...

6 нояб. 2022 г. · ISCHEMIA-EXTEND will continue to follow surviving participants into 2025 for a projected median of ~10 years to increase the precision around ...

21 апр. 2023 г. · The interim report of the ISCHEMIA-EXTEND study shows that there was no difference in all-cause mortality in 7 years, but there was a lower risk ...

4 окт. 2022 г. · The ISCHEMIA-EXTEND observational study is the long-term follow-up of surviving participants (projected median of 10 years) with chronic coronary disease from ...

6 нояб. 2022 г. · Cardiovascular deaths were significantly lower among patients randomized to an invasive strategy, whereas noncardiovascular deaths were significantly higher.

6 нояб. 2022 г. · ISCHEMIA-EXTEND lacks insight on patient-reported health status, including symptom burden, functional status, and health-related quality of life ...

The ISCHEMIA-EXTEND observational study is the long-term follow-up of surviving participants (projected median of 10 years) with chronic coronary disease from ...

What is ISCHEMIA-EXTEND? ISCHEMIA-EXTEND is the long-term follow-up of randomized, surviving participants in the ISCHEMIA and ISCHEMIA-CKD trials.

10 нояб. 2022 г. · In ISCHEMIA-EXTENDed, ISCHEMIA patients underwent additional follow-up after the end of the main study, resulting in a median follow-up of 5.7 ...

Funded by the National Heart, Lung, and Blood Institute, the ISCHEMIA-EXTEND observational study is the long-term follow-up of surviving participants (projected ...